Detalhe da pesquisa
1.
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone.
Leuk Lymphoma
; 58(11): 2615-2623, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28395585